Members of the caspase family have been implicated as key mediators of apop
tosis in mammalian cells. However, few of their substrates are known to hav
e physiological significance in the apoptotic process. We focused our scree
ning for caspase substrates on cytoskeletal. proteins. We found that an act
in binding protein, filamin, was cleaved from 280 kDa to 170, 150, and 120
kDa major N-terminal fragments, and 135,120, and 110 kDa major C-terminal f
ragments when apoptosis was induced by etoposide in both the human monoblas
tic leukemia cell line U937, and the human T lymphoblastic cell line Jurkat
. The cleavage of filamin was blocked by a cell permeable inhibitor of casp
ase-3-like protease, Ac-DEVD-cho, but not by an inhibitor of caspase-1-like
protease, Ae-YVAD-cho. These results suggest that filamin is cleaved by a
caspase-3-like protease. To examine whether caspase-3 cleaves filamin in vi
tro, we prepared a recombinant active form of caspase-3 directly using a Pi
chia pastoris overexpression system. When we applied recombinant active cas
pase-3 to the cell lysate of U937 and Jurkat cells, filamin was cleaved int
o the same fragments seen in apoptosis-induced cells in vivo. Platelet fila
min was also cleaved directly from 280 kDa to 170, 150, and 120 kDa N-termi
nal fragments, and the cleavage pattern was the same as observed in apoptot
ic human cells in vivo. These results suggest that filamin is an in vivo su
bstrate of caspase-3.